Otros idiomas EuBiologics Co., Ltd.

Acciones

A206650

KR7206650004

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 14/05/2024			Varia. Cinco días.	Varia. 1 de enero.
12.840 ^KRW	-0,47 %		-4,89 %	+11,94 %

14/02	Reservas de vacunas contra el cólera, "vacías" ante aumento de casos	RE
29/01	Zimbabue lanza una campaña de vacunación contra el cólera puerta a puerta	RE

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

EuBiologics co.,Ltd - SNAP Platform enters Phase I clinical studies for RSV	13/05
Gavi and UNICEF welcome approval of new oral cholera vaccine	19/04
Gavi and Unicef Welcome Approval of New Oral Cholera Vaccine [press release]	19/04
What's Behind the Worldwide Shortage of Cholera Vaccines? for Starters, They're Only Made By One Company [analysis]	13/03
Zimbabwe launches door-to-door cholera vaccination campaign	29/01
Pop Biotechnologies and Eubiologics' Eucorvac-19 Vaccine Hits Target in Phase 3 Trial	14/07/23
Gavi - Global vaccine alliance outlines path to sustainable cholera vaccine supply	23/05/23
EuBiologics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	21/03/23
POP Biotechnologies' SNAP Vaccine System Safe and Effective in a Phase II Clinical Trial for COVID-19	01/12/22
POP Biotechnologies' next-gen vaccine technology to enter COVID-19 phase III clinical trials	07/02/22
Eubiologics Co., Ltd. Announces Phase Iii Clinical Trial Ind Approval of Eucorvac-19, Covid-19 Vaccine Candidate, in South Korea	03/02/22
Clips Co., Ltd. announced that it expects to receive KRW 2.50003 billion in funding from EuBiologics Co., Ltd., SK bioscience Co.,Ltd., BNC Korea Co., Ltd.	27/01/22
SK bioscience : S.Korea to begin producing Novavax COVID-19 vaccine as early as June	12/04/21
EuBiologics Gets an IND Approval for Phase I/II Clinical Trial of 'EuCorVac-19' in Korea	21/01/21
EuBiologics Co., Ltd.(KOSDAQ:A206650) added to S&P Global BMI Index	23/09/19
ATGC Co., Ltd. announced that it has received KRW 2.1 billion in funding from EuBiologics Co., Ltd.	10/01/19
ATGC Co., Ltd. announced that it expects to receive KRW 2.1 billion in funding from EuBiologics Co., Ltd.	04/01/19
EuBiologics Co., Ltd. announced that it has received KRW 30.00000351 billion in funding	30/04/18
EuBiologics Co., Ltd. announced that it expects to receive KRW 30 billion in funding	12/02/18
Global Health Investment Fund I, LLC, managed by Global Health Investment Advisors, LLC acquired 6.19% stake in EuBiologics Co., Ltd..	02/02/17

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas EuBiologics Co., Ltd.

Acciones

A206650

KR7206650004

Otros idiomas

Filtros